Growth Metrics

Biogen (BIIB) Income from Non-Controlling Interests (2016 - 2023)

Biogen has reported Income from Non-Controlling Interests over the past 13 years, most recently at -$800000.0 for Q4 2023.

  • Quarterly results put Income from Non-Controlling Interests at -$800000.0 for Q4 2023, up 11.11% from a year ago — trailing twelve months through Sep 2024 was -$800000.0 (down 366.67% YoY), and the annual figure for FY2023 was $400000.0, up 100.47%.
  • Income from Non-Controlling Interests for Q4 2023 was -$800000.0 at Biogen, down from -$200000.0 in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for BIIB hit a ceiling of $577.0 million in Q2 2021 and a floor of -$388.7 million in Q4 2021.
  • Median Income from Non-Controlling Interests over the past 4 years was -$300000.0 (2020), compared with a mean of $9.2 million.
  • Peak annual rise in Income from Non-Controlling Interests hit 795.96% in 2021, while the deepest fall reached 129466.67% in 2021.
  • Biogen's Income from Non-Controlling Interests stood at -$300000.0 in 2020, then plummeted by 129466.67% to -$388.7 million in 2021, then soared by 99.77% to -$900000.0 in 2022, then increased by 11.11% to -$800000.0 in 2023.
  • The last three reported values for Income from Non-Controlling Interests were -$800000.0 (Q4 2023), -$200000.0 (Q3 2023), and $1.7 million (Q2 2023) per Business Quant data.